论文部分内容阅读
卵巢癌确诊时70%已属晚期,治疗困难,虽经数十年努力,但治疗效果仍在原地徘徊。至今有关卵巢癌的治疗仍有一些问题未达统一。手术治疗的时间、方法、切除范围、淋巴清扫、大网膜切除范围、肠管病灶处理、复发者再次手术、手术与化疗配合等有许多问题未臻一致。所以还需要共同探索,更需以充分的实践和理论依据来阐述有关问题。以百花齐放、百家争鸣的原则,既借鉴国外经验,也有我国自己的经验,以期对患者有益,使医疗水平进一步提高。为此,本刊开辟《学术争鸣》栏目,请妇产科同道积极参与。本文是探讨有关卵巢上皮癌复发患者手术治疗问题,希望能对卵巢癌的治疗有所裨益。
70% of ovarian cancer diagnosis is already advanced, the treatment is difficult, although after decades of efforts, but the treatment effect is still wandering in place. There are still some problems about the treatment of ovarian cancer so far. Surgical treatment time, methods, resection range, lymphatic dissection, omental resection range, bowel disease treatment, recurrence reoperation, surgery and chemotherapy with many problems have not yet been consistent. Therefore, we also need to explore together and explain the relevant issues with sufficient practical and theoretical evidence. The principle of “letting all flowers bloom and all schools of thought contend” draws on both foreign experience and our own experience in the hope of benefiting patients so that the medical standards can be further enhanced. To this end, the magazine opened the “academic debate” section, obstetrics and gynecology colleagues to actively participate. This article is to explore the surgical treatment of patients with recurrence of epithelial ovarian cancer, hoping to benefit the treatment of ovarian cancer.